At Micronoma, we turn to science first to guide us down the road to delivering the first diagnostic platform technology using the microbiome to detect early-stage cancer. At the same time, we keep a watchful eye on our resources so we can steer clear of the...
It’s no exaggeration to say the development of Micronoma’s Oncobiota™ microbiome-driven liquid-biopsy technology to detect cancer at an early stage would not be possible without extensive expertise and use of machine learning (ML) tools. Micronoma’s proprietary...
While researchers have typically seen microbes only as contaminants and discarded them, Micronoma has set itself apart by seeing the treasure trove of opportunity microbes represent to detect and identify cancer early. Using liquid biopsy–a simple blood...
Micronoma’s founders each contribute unique skill sets and know-how to the company’s cutting-edge cancer detection platform. For any team to be successful, each member must bring something unique to the table. At the same time, the individual pieces and parts must...
